Ethical and Regulatory Problems of Molecular Imaging / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
;
: 140-142, 2004.
Artigo
em Coreano
| WPRIM
| ID: wpr-224414
ABSTRACT
As a molecular imaging is the most up-to-date technology in Nuclear Medicine, it has complicate ethical and regulatory problems. For animal experiment, we have to follow institutional animal care committee. For clinical experiment, we have to get approval of Institutional Review Board according to Helsinki declaration. In addition, approval from Korea Food and Drug Administration (KFDA) is essential for manufacturing and commercialization. However, too much regulation would suppress development of new technology, which would result in the loss of national competitive power. In addition, most new radioactive ligands for molecular imaging are administered to human at sub-pharmacological and sub-toxicological level. In conclusion, a balanced regulation is essential for the safety of clinical application and development of new technology.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
United States Food and Drug Administration
/
Comitês de Ética em Pesquisa
/
Experimentação Animal
/
Comitês de Cuidado Animal
/
Ética
/
Imagem Molecular
/
Declaração de Helsinki
/
Coreia (Geográfico)
/
Ligantes
/
Medicina Nuclear
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Coreano
Revista:
Korean Journal of Nuclear Medicine
Ano de publicação:
2004
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS